Bilateral Testicular Germ Cell Tumours: an Increasing Incidence and Prevention by Chemotherapy
- 1 October 1988
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 62 (4) , 374-376
- https://doi.org/10.1111/j.1464-410x.1988.tb04368.x
Abstract
Summary— Of 120 patients with germ cell tumours of the testis, 6 (5%) developed contralateral tumours; 63 patients received cisplatin-based combination chemotherapy for metastatic disease and none developed contralateral disease. By contrast, of 57 patients treated with orchiectomy alone or abdominal radiotherapy, 5 (8.8%) developed contralateral disease.This publication has 10 references indexed in Scilit:
- Changes in testicular cancer in ScotlandEuropean Journal of Cancer and Clinical Oncology, 1987
- Carcinoma in situ of the contralateral testis.BMJ, 1987
- Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.BMJ, 1986
- Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982British Journal of Cancer, 1986
- RADIATION TREATMENT OF CARCINOMA-IN-SITU OF TESTISThe Lancet, 1986
- Bilateral testicular germ cell tumors. Report of nine cases and review of the literatureCancer, 1986
- Bilateral Synchronous Germ Cell TumorsJournal of Urology, 1985
- Bilateral Germ Cell Tumours of the TestisBritish Journal of Urology, 1980
- Sequential Bilateral Germ Cell Tumors of the Testis Despite Interval ChemotherapyJournal of Urology, 1979
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISPublished by Elsevier ,1979